HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637H909. A total of 4 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $327,000 | -20.4% | 37,900 | -12.7% | 0.00% | -100.0% |
| Q1 2016 | $411,000 | -27.6% | 43,400 | +32.3% | 0.00% | 0.0% |
| Q4 2015 | $568,000 | +21.9% | 32,800 | -5.5% | 0.00% | – |
| Q3 2015 | $466,000 | -40.9% | 34,700 | -0.6% | 0.00% | -100.0% |
| Q2 2015 | $788,000 | +124.5% | 34,900 | +41.9% | 0.00% | – |
| Q1 2015 | $351,000 | -40.5% | 24,600 | -59.7% | 0.00% | -100.0% |
| Q4 2014 | $590,000 | +47.1% | 61,100 | +38.5% | 0.00% | – |
| Q3 2014 | $401,000 | -28.0% | 44,100 | -21.8% | 0.00% | -100.0% |
| Q2 2014 | $557,000 | +52.2% | 56,400 | +95.8% | 0.00% | – |
| Q1 2014 | $366,000 | -33.1% | 28,800 | -21.1% | 0.00% | -100.0% |
| Q4 2013 | $547,000 | +149.8% | 36,500 | +84.3% | 0.00% | – |
| Q3 2013 | $219,000 | +27.3% | 19,800 | -8.3% | 0.00% | – |
| Q2 2013 | $172,000 | – | 21,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 27,600 | $1,101,000 | 0.00% |
| JPMORGAN CHASE & CO | 155,400 | $6,197,000 | 0.00% |
| SIMPLEX TRADING, LLC | 5,500 | $219,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |